Menu
GeneBe

SFXN4

sideroflexin 4, the group of Solute carrier family 56, sideroflexins

Basic information

Region (hg38): 10:119140766-119165714

Links

ENSG00000183605NCBI:119559OMIM:615564HGNC:16088Uniprot:Q6P4A7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Supportive), mode of inheritance: AR
  • growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Moderate), mode of inheritance: AR
  • growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (Strong), mode of inheritance: AR
  • mitochondrial disease (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Combined oxidative phosphorylation deficiency 18ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Hematologic; Neurologic24119684

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SFXN4 gene.

  • not provided (115 variants)
  • not specified (21 variants)
  • Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome (15 variants)
  • Inborn genetic diseases (14 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SFXN4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
14
clinvar
6
clinvar
20
missense
17
clinvar
2
clinvar
19
nonsense
2
clinvar
1
clinvar
3
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
3
clinvar
4
splice region
1
4
3
8
non coding
34
clinvar
49
clinvar
83
Total 6 4 18 50 55

Highest pathogenic variant AF is 0.0000132

Variants in SFXN4

This is a list of pathogenic ClinVar variants found in the SFXN4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-119140970-G-T Likely benign (Jul 09, 2018)1196188
10-119140971-T-C Likely benign (Jul 09, 2018)1194864
10-119140986-C-T Likely benign (Sep 17, 2018)1186555
10-119141037-C-T Likely benign (Jun 16, 2018)1191001
10-119141097-G-A Likely benign (Sep 05, 2018)1188485
10-119141113-C-T Benign (Jun 16, 2018)1237656
10-119141239-C-T SFXN4-related disorder Benign (Mar 02, 2020)3052198
10-119141285-G-A Inborn genetic diseases Uncertain significance (Dec 27, 2023)3160976
10-119141316-G-A Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome Pathogenic (Apr 27, 2019)638327
10-119141328-T-C Likely benign (Oct 13, 2022)713829
10-119141334-A-C Likely benign (Jan 04, 2024)2868876
10-119141464-AT-A Benign (Aug 06, 2019)1268158
10-119141464-ATT-A Benign (Aug 06, 2019)1225080
10-119141507-CT-C Benign (Aug 21, 2019)1256922
10-119141507-CTT-C Likely benign (Aug 06, 2019)1211805
10-119141507-C-CT Benign (Aug 10, 2019)1224878
10-119141507-C-CTT Benign (Aug 12, 2019)1256640
10-119145910-T-C Benign (Jun 14, 2018)683836
10-119146224-G-C Likely benign (May 24, 2022)1909545
10-119146228-G-A Likely benign (Dec 31, 2019)794063
10-119146241-CA-C Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome Pathogenic (Dec 31, 2017)689787
10-119146243-A-G Uncertain significance (Jul 16, 2020)1303934
10-119146299-A-G not specified Likely benign (Jan 13, 2024)507885
10-119146333-T-A Uncertain significance (Aug 11, 2022)1933980
10-119146354-C-G Likely pathogenic (Jul 05, 2022)2076813

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SFXN4protein_codingprotein_codingENST00000355697 1424901
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.24e-70.9461256880601257480.000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7651561850.8420.000009552172
Missense in Polyphen3144.4460.69748532
Synonymous0.3266467.40.9490.00000371626
Loss of Function1.901525.30.5920.00000149265

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004480.000426
Ashkenazi Jewish0.00009920.0000992
East Asian0.00005440.0000544
Finnish0.0005870.000554
European (Non-Finnish)0.0002230.000211
Middle Eastern0.00005440.0000544
South Asian0.0003270.000327
Other0.0003740.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Potential iron transporter. {ECO:0000250}.;
Disease
DISEASE: Combined oxidative phosphorylation deficiency 18 (COXPD18) [MIM:615578]: An autosomal recessive disorder of mitochondrial dysfunction characterized by intrauterine growth retardation, hypotonia, visual impairment, speech delay, and lactic acidosis associated with decreased mitochondrial respiratory chain activity. Affected patients may also show hematologic abnormalities, mainly macrocytic anemia. {ECO:0000269|PubMed:24119684}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0633

Intolerance Scores

loftool
rvis_EVS
-0.71
rvis_percentile_EVS
14.4

Haploinsufficiency Scores

pHI
0.0456
hipred
N
hipred_score
0.281
ghis
0.583

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.796

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sfxn4
Phenotype
hematopoietic system phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
sfxn4
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
ion transmembrane transport;iron ion homeostasis
Cellular component
mitochondrial inner membrane;integral component of membrane;intracellular membrane-bounded organelle
Molecular function
ion transmembrane transporter activity